In connection with the implementation of the project titled “Design and development of nanoparticle-RNA-based drugs for use in anti-cancer therapy, including the construction of a nanoparticle platform for the targeted delivery of therapeutic nucleic acids” by Biotechna SA under Contract No. 2022/ABM/06/ 00005-00 for co-financing of a commercial project under the Call for Proposals for the development of targeted or personalized medicine based on medicinal products derived from nucleic acids and small-molecule compounds, the Contracting Authority is conducting market research regarding the costs of purchasing and delivering a CEP probe.
To submit a bid, please review the detailed terms of the announcement included in Request for Proposals No. 61/2026 and submit the completed offer form along with the product and price list (Excel).